AbbVie plans product launches in India from global portfolio

In addition, the drug maker is also considering making India part of its global Phase-3 clinical trials for potential therapies under development. This would help the company cut the time to market.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3nyGvzu
via IFTTT